RE:RE:RE:RE:Enough on Trogarzo/Rukobia - Back to what matters - TH-1902 I know you're an angry skeptic Momo, but your characterization is wrong. He has stated the various facts the company has mentioned (1b start date, some patients rolling in from 1a, etc...). Those are all statements of fact from management, not guessing. He has other info he has gleaned and he is trying to put together a scenario analysis for an investor to think about. Scenarios are speculative, but one of the various paths laid out will occur since he speculates from no efficacy all the way to ,ultiple tumor efficacies.
So to correct your statement - there is a source (management and his other sources), the info is either factual or based on comps who've trodden the same path, he's definitely interpolating the holes in the data based on that (of course any investment in an unknown outcome involves speculation or you should just buy bonds with known incomes), it's pretty balanced between failure and success. Of course, any investor hopes for success but is clear-eyed enough to know risks go both ways. At least try to be analytical, move the analysis forward either bullish or bearish but with facts and good thoughtful conclusions, instead of just snarky pablum.
Momo25 wrote: He has no source, nor viable information. Just iterative speculation. I am suspecting, he runs a biotech fund and tries to keep TH shareholders as much optimistic as he could. That's it, that's all.